Jolkinolide B inhibits glycolysis by downregulating hexokinase 2 expression through inactivating the Akt/mTOR pathway in non-small cell lung cancer cells
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Jolkinolide B inhibits glycolysis by downregulating hexokinase 2 expression through inactivating the Akt/mTOR pathway in non-small cell lung cancer cells
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR BIOCHEMISTRY
Volume 119, Issue 6, Pages 4967-4974
Publisher
Wiley
Online
2018-02-01
DOI
10.1002/jcb.26742
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ent-Abietane Lactones from Euphorbia
- (2017) Jia-Zhuo Lai et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Albendazole inhibits HIF-1α-dependent glycolysis and VEGF expression in non-small cell lung cancer cells
- (2017) Fang Zhou et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Glycometabolic adaptation mediates the insensitivity of drug-resistant K562/ADM leukaemia cells to adriamycin via the AKT-mTOR/c-Myc signalling pathway
- (2017) Xueyan Zhang et al. Molecular Medicine Reports
- MicroRNA-124 suppresses proliferation and glycolysis in non–small cell lung cancer cells by targeting AKT–GLUT1/HKII
- (2017) Xiaojian Zhao et al. TUMOR BIOLOGY
- Jolkinolide A and Jolkinolide B Inhibit Proliferation of A549 Cells and Activity of Human Umbilical Vein Endothelial Cells
- (2017) Lei Shen et al. MEDICAL SCIENCE MONITOR
- Inhibition of glycolytic enzyme hexokinase II (HK2) suppresses lung tumor growth
- (2016) Huanan Wang et al. Cancer Cell International
- Jolkinolide B induces apoptosis and inhibits tumor growth in mouse melanoma B16F10 cells by altering glycolysis
- (2016) Caixia Gao et al. Scientific Reports
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Anti-metastatic effect of jolkinolide B and the mechanism of activity in breast cancer MDA-MB-231 cells
- (2015) CHAO SUN et al. Oncology Letters
- Review of aerobic glycolysis and its key enzymes - new targets for lung cancer therapy
- (2015) Xue-bing Li et al. Thoracic Cancer
- RETRACTED ARTICLE: Text mining and network analysis of molecular interaction in non-small cell lung cancer by using natural language processing
- (2014) Jun Li et al. MOLECULAR BIOLOGY REPORTS
- Cancer-generated lactic acid: a regulatory, immunosuppressive metabolite?
- (2013) Stephen Yiu Chuen Choi et al. JOURNAL OF PATHOLOGY
- Jolkinolide B from Euphorbia fischeriana Steud induces in human leukemic cells apoptosis via JAK2/STAT3 pathways
- (2012) Jia-He Wang et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- MicroRNA-143 (miR-143) Regulates Cancer Glycolysis via Targeting Hexokinase 2 Gene
- (2012) Rong Fang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- miR-143 regulates hexokinase 2 expression in cancer cells
- (2012) A Peschiaroli et al. ONCOGENE
- Jolkinolide B induces apoptosis in MCF-7 cells through inhibition of the PI3K/Akt/mTOR signaling pathway
- (2012) HUI-YU XU et al. ONCOLOGY REPORTS
- The acidity of the tumor microenvironment is a mechanism of immune escape that can be overcome by proton pump inhibitors
- (2012) Matteo Bellone et al. OncoImmunology
- Jolkinolide B from Euphorbia fischeriana Steud induces apoptosis in human leukemic U937 cells through PI3K/Akt and XIAP pathways
- (2011) Jia-He Wang et al. MOLECULES AND CELLS
- The Warburg and Crabtree effects: On the origin of cancer cell energy metabolism and of yeast glucose repression
- (2010) Rodrigo Diaz-Ruiz et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Analyses of Resected Human Brain Metastases of Breast Cancer Reveal the Association between Up-Regulation of Hexokinase 2 and Poor Prognosis
- (2009) D. Palmieri et al. MOLECULAR CANCER RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now